Research

Redoxis holds a portfolio of research projects for the treatment of chronic inflammatory and autoimmune diseases, linked together by a large unmet medical need and large patient populations or high-value niche therapy areas. Redoxis research actively targets pathways identified by forward genetics with the aim of identifying and developing novel small molecule therapies. Redoxis closely collaborates with academic partners in Sweden, Europe and the U.S. to acquire or license novel projects within Redoxis’ research expertise.